General form of registration statement for all companies including face-amount certificate companies

Intangible Assets, Net

v3.19.2
Intangible Assets, Net
6 Months Ended 12 Months Ended
Jun. 30, 2019
Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]    
Intangible Assets, Net

NOTE 4 – INTANGIBLE ASSETS, net

 

Intangible assets, net, consists of the following as of:

 

    June 30, 2019 (Unaudited)     December 31, 2018  
Patents   $ 585,589     $ 578,326  
Less accumulated amortization     (311,540 )     (292,512 )
      274,049       285,814  
Patents pending     155,811       148,720  
Total intangible assets, net   $ 429,860     $ 434,534  

 

Patents are amortized straight-line over a period of fifteen years. Amortization expense was $7,766 and $19,028 for the three and six-months ended June 30, 2019, respectively. Amortization expense was $6,717 and $15,235 for the three and six-months ended June 30, 2018, respectively.

 

The Company has capitalized costs for several patents that are still pending. In those instances, the Company has not recorded any amortization. The Company will commence amortization when these patents are approved.

 

The Company owns 28 issued patents, including 14 in the United States and 14 others in Europe, Canada, China, India, Japan, and Hong Kong. These patents will expire beginning in 2023 through 2028, subject to any patent term extensions of the individual patent. The Company has 1 patent application pending in the United States and 2 foreign patent applications pending in Europe and Brazil.

NOTE 5 – INTANGIBLE ASSETS, net

 

Intangible assets, net, consists of the following as of December 31:

 

    2018     2017  
Patents   $ 578,326     $ 493,027  
Less accumulated amortization     (292,512 )     (263,843 )
      285,814       229,184  
Patents pending     148,720       197,426  
Total intangible assets, net   $ 434,534     $ 426,610  

 

Patents are amortized straight-line over a period of fifteen years. Amortization expense was $28,669 and $23,568 for the years ended December 31, 2018 and 2017, respectively.

 

The Company has capitalized costs for several patents that are still pending. In those instances, the Company has not recorded any amortization. The Company will commence amortization when these patents are approved.

 

The Company owns 28 issued patents, including 14 in the United States and 14 others in Europe, Canada, China, India, Japan, and Hong Kong. These patents will expire beginning in 2023 through 2028, subject to any patent term extensions of the individual patent. The Company has 1 patent application pending in the United States and 2 patent applications pending in Europe and Brazil.